2665 related articles for article (PubMed ID: 7872695)
1. Combined activity of interleukin-1 alpha or TNF-alpha and doxorubicin on multidrug resistant cell lines: evidence that TNF and DXR have synergistic antitumor and differentiation-inducing effects.
Borsellino N; Crescimanno M; Flandina C; Flugy A; D'Alessandro N
Anticancer Res; 1994; 14(6B):2643-8. PubMed ID: 7872695
[TBL] [Abstract][Full Text] [Related]
2. TNF-induced apoptosis in multidrug resistant friend erythroleukemia is not influenced by the P-glycoprotein and glutathione status of the cell line.
Flugy A; Borsellino N; D'Alessandro N
Oncol Res; 1995; 7(10-11):559-64. PubMed ID: 8866668
[TBL] [Abstract][Full Text] [Related]
3. The apoptotic signaling of TNF-alpha in multidrug resistant Friend leukemia cells.
D'Alessandro N; Flugy A; Tolomeo M; Dusonchet L
Anticancer Res; 1998; 18(4C):3065-72. PubMed ID: 9713511
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype.
Safrit JT; Berek JS; Bonavida B
Gynecol Oncol; 1993 Feb; 48(2):214-20. PubMed ID: 8428693
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines.
Schiller JH; Bittner G; Storer B; Willson JK
Cancer Res; 1987 Jun; 47(11):2809-13. PubMed ID: 3105867
[TBL] [Abstract][Full Text] [Related]
6. Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin.
Evans CH; Baker PD
Cancer Res; 1992 Nov; 52(21):5893-9. PubMed ID: 1356622
[TBL] [Abstract][Full Text] [Related]
7. Combinative growth-inhibitory effects of interferon-alpha and Doxorubicin on multidrug-resistant tumor-cell lines.
Leonardi V; Borsellino N; Crescimanno M; Flandina C; Flugy A; Dalessandro N
Oncol Rep; 1994 Jan; 1(1):161-4. PubMed ID: 21607328
[TBL] [Abstract][Full Text] [Related]
8. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.
Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F
Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antiproliferative effects of the combination of interleukin-1 alpha and doxorubicin against human melanoma cells.
Mimnaugh EG; Monti E; Sebers S; Stetler-Stevenson M; Sinha BK
Oncol Res; 1992; 4(10):401-12. PubMed ID: 1292755
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of IL-4 and TNF-alpha in the induction of monocytic differentiation of a mouse myeloid leukaemic cell line (WEHI-3B JCS).
Leung KN; Mak NK; Fung MC; Hapel AJ
Immunology; 1994 Jan; 81(1):65-72. PubMed ID: 8132222
[TBL] [Abstract][Full Text] [Related]
11. The relationship between multidrug resistance and tumor necrosis factor resistance in an EL4 cell line model.
Ujhazy P; Chen YF; Fredericks W; Ho RL; Mihich E; Baker RM; Ehrke MJ
Cancer Commun; 1990; 2(5):181-8. PubMed ID: 1973358
[TBL] [Abstract][Full Text] [Related]
12. Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine.
Porter CW; Ganis B; Rustum Y; Wrzosek C; Kramer DL; Bergeron RJ
Cancer Res; 1994 Nov; 54(22):5917-24. PubMed ID: 7954423
[TBL] [Abstract][Full Text] [Related]
13. Effect of buthionine sulfoximine on the sensitivity to doxorubicin of parent and MDR tumor cell lines.
Crescimanno M; Borsellino N; Leonardi V; Flandina C; Flugy A; Rausa L; D'Alessandro N
J Chemother; 1994 Oct; 6(5):343-8. PubMed ID: 7861199
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of TNF-alpha, IL-1, and IFN-gamma against three human osteosarcoma cell lines.
Jia SF; Kleinerman ES
Lymphokine Cytokine Res; 1991 Aug; 10(4):281-4. PubMed ID: 1932372
[TBL] [Abstract][Full Text] [Related]
17. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
Arora A; Seth K; Kalra N; Shukla Y
Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
[TBL] [Abstract][Full Text] [Related]
18. Effects of 8-chloro-cyclic adenosine monophosphate on the growth and sensitivity to doxorubicin of multidrug-resistant tumour cell lines.
Borsellino N; Crescimanno M; Leonardi V; D'Alessandro N
Pharmacol Res; 1994 Jul; 30(1):81-90. PubMed ID: 7831198
[TBL] [Abstract][Full Text] [Related]
19. Purification and further characterization of a non-tumor necrosis factor alpha or beta differentiation-inducing cytokine, P48.
Leftwich JA; Hall RE
Cancer Res; 1989 Aug; 49(16):4459-65. PubMed ID: 2663142
[TBL] [Abstract][Full Text] [Related]
20. Synergistic regulatory effects of TNF alpha, IL-1 alpha and IFN alpha on the growth and differentiation of Daudi lymphoma cells.
Santavenere E; Di Pietro R; Centurione MA; Di Domenicantonio L; Trubiani O; Rana RA
Cell Biol Int; 1996 May; 20(5):335-8. PubMed ID: 8688848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
